News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Isabella Michelon: Meta-analysis of 2000+ patients with HER2-low and MBC
Isabella Michelon/LinkedIn
Nov 24, 2024, 19:37

Isabella Michelon: Meta-analysis of 2000+ patients with HER2-low and MBC

Isabella Michelon, 6th year medical student at the Catholic University of Pelotas, shared a recent article on X:

“Proud to share our work in Therapeutic Advances in Medical Oncology.

Our meta-analysis of 2000+ patients with HER2-low and MBC reveals a 50% reduction in the risk of progression and death with ADCs compared to chemotherapy.”

Title: Antibody–drug conjugates in patients with advanced/metastatic HER2-low-expressing breast cancer: a systematic review and meta-analysis

Authors: Isabella Michelon, Maria Inez Dacoregio, Maysa Vilbert, Jonathan Priantti, Caio Ernesto do Rego Castro, Lucas Vian, Paolo Tarantino, Evandro de Azambuja, and Ludimila Cavalcante

Isabella Michelon

For more updates, follow OncoDaily.

antibody antibody drug Breast Cancer Caio Ernesto do Rego Castro cancer chemotherapy drug Evandro de Azambuja HER2-low Isabella Michelon Jonathan Priantti Lucas Vian Ludimila Cavalcant Maria Inez Dacoregio Maysa Vilbert MBC meta-analysis OncoDaily Oncology Paolo Tarantino Therapeutic Advances in Medical Oncology
Special Coverage
Blog
Dec 22, 2024, 04:24
Jordan Rathkopf: As 2024 winds down, we’ve been reflecting on what a year it’s been
Insight
Dec 22, 2024, 00:21
Eric J. Small: ASCO/Conquer Cancer Foundation Felix Feng Prostate Cancer YIA is now fully endowed
Blog
Dec 21, 2024, 22:40
50 Years of History, a Future to Write Together - AIEOP
Science
Dec 21, 2024, 22:37
Breaking Down the Impact of Ionizing Radiation on Cancer
Blog
Dec 21, 2024, 22:35
Santiago Viteri: Latest findings from the BR.31 trial presented at the 2024 ESMO Congress
Blog
Dec 21, 2024, 22:33
ABIM will develop two new assessment options focusing on breast cancer and hematologic neoplasms
Blog
Dec 21, 2024, 22:28
Adekemi Oyewusi: EDUCARE - Supporting the medical treatment and education of those impacted by childhood cancer
Blog
Dec 21, 2024, 22:26
Anas Younes: Transforming outcomes for people living with Blood Cancer
Blog
Dec 21, 2024, 19:42
Ruben Mesa: Over 200 research staff of Atrium Health Wake Forest Baptist trained on Just Ask Increasing Diversity in Cancer Clinical Trials
Blog
Dec 21, 2024, 19:39
Kyaw Thein: Investigational Treatments for Thyroid and Head and Neck Cancers
Blog
Dec 21, 2024, 19:25
Hesham ElGhazaly: From an academic institution into a globally recognized hub for healthcare, research and innovation
Blog
Dec 21, 2024, 19:21
Douglas Flora: The 19 Words I’m Learning to Embrace as a Leader in 2025